This guidance document has been developed in order to support teams to work collaboratively with people living with diabetes to ensure the best possible outcomes, before, during and after moving on to HCL therapy.

The ABCD audit programme featured at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024) which was held on 6-9 March 2024 in Florence, Italy.

Please note this programme is subject to change

Testosterone replacement in men with Type 2 Diabetes lowers HbA1c
ABCD Worldwide Audit of Testosterone and Diabetes.

Authors:
H.Jones, K. Darzy, R. Troke, U. Dashora, A. Haider, R. Ryder

Is hybrid closed-loop therapy associated with weight gain? Results from the ABCD Closed-Loop audit of the NHS England Pilot 

Authors: TSJ Crabtree; TP Griffin; YW Yap; P Narendran; G Gallen; J Elliott; MA Karamat; S Saraf; L Leelarathna; S Hussain; A Lumb; REJ Ryder; P Choudhary; EG Wilmot on behalf of all ABCD Closed-Loop Pilot audit contributors

Diabetes distress and quality of life in individuals using hybrid closed-loop therapy as part of the NHS England pilot: Results from the ABCD audit.

Authors:

TSJ Crabtree; TP Griffin; YW Yap; P Narendran; G Gallen; J Elliott; MA Karamat; S Saraf; L Leelarathna; S Hussain; A Lumb; REJ Ryder; P Choudhary; EG Wilmot on behalf of all ABCD Closed-Loop Pilot audit contributors

To shine a light on the funding available for diabetes research from ABCD, we're speaking to those who were awarded a Diabetes Care Trust and ABCD Research Grant.

In our first interview we hear from Gordon Sloan, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust who was awarded funding for his project exploring potential brain imaging biomarkers of Painful-Diabetic Peripheral Neuropathy (DPN).